Moderna's Cancer Vaccine: A Breakthrough Driven by AI
By Editor • August 27, 2026 • 1 min read
Moderna and Merck's personalized cancer vaccine, intismeran autogene, has sparked excitement following its success in a late-stage trial. If approved, it could revolutionize treatment, being the first medicine with mRNA instructions generated by a computer.
Source: www.statnews.com